| Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
|---|
| 02/25/2004 | CN1478068A Process for preparation of iopamidol and new intermediates therein |
| 02/25/2004 | CN1139586C Process for stereoselective preparation of hetero-bicyclic alcohol enantiomer |
| 02/25/2004 | CN1139584C Heterocyclic compounds, method for preparing and medicine composition containing same |
| 02/24/2004 | US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 02/19/2004 | WO2004014966A1 Microstructure chain transfer agents for anionic polymerization |
| 02/19/2004 | WO2004014899A1 Thiophene compounds |
| 02/19/2004 | WO2004014890A1 Method of purifying lactide |
| 02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
| 02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
| 02/19/2004 | US20040034027 E.g.N-(carbamimidoylphenyl)-N'-((1-(4-nitrophenyl)ethyl-2-phenyl -malonamide formate; reversible enzyme inhibitors of blood factor VIIa; a strong antithrombotic to treat thrombo-embolic diseases and restenoses; cardiovascular disorders |
| 02/19/2004 | CA2493908A1 Thiophene compounds |
| 02/17/2004 | US6693204 Using vertical cyliner refiner; intakes, agitation, countercurrent gas flow, discharging |
| 02/17/2004 | US6692657 Alkenyl compound with 2,3-difluorophenyl group |
| 02/17/2004 | CA2124680C Piperazine derivatives as 5-ht1a antagonists |
| 02/12/2004 | WO2004013121A2 Preparation of lactic acid derivatives and their use |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | US20040030129 NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient |
| 02/12/2004 | US20040029965 Formulations for reducing or eliminating toxicity of enviromental hormones containing ursodeoxycholic acid |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029720 Supported group 8-10 transition metal olefin polymerization catalysts |
| 02/11/2004 | EP1388529A2 Stable ethylene inhibiting compounds and methods for their preparation |
| 02/11/2004 | EP1387720A1 Reactor for gas/liquid or gas/liquid/solid reactions |
| 02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
| 02/11/2004 | CN1473824A Method for catalytically synthesizing 1,4-dioxane using granular solid super strong acid |
| 02/11/2004 | CN1473823A Process for producing high purity 1,4-dioxane |
| 02/05/2004 | WO2004011451A1 Process for industrially producing optically active 1,4-benzodioxane derivative |
| 02/05/2004 | WO2004011420A1 Process for producing optically active 6-sulfonyloxymethyl-1,3-dioxan-4-ylacetic acid derivative |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | US20040024227 For continuous processing |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024045 Glucagon antagonists/inverse agonists |
| 02/05/2004 | US20040022923 Marine oils with reduced levels of contaminants |
| 02/04/2004 | CN1473146A Novel indanylidene compounds |
| 02/04/2004 | CN1137118C Water soluble azoles as broad-spectrun antifungals |
| 02/04/2004 | CN1137116C Dioxane derivatives, liquid-crystal compositions containing same and liquid-crystal display devices made by using same |
| 02/03/2004 | US6685995 Low voltage, wide temperature range driving; high speed response |
| 01/29/2004 | US20040019041 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2004 | US20040019039 Substituted piperazines and diazepanes |
| 01/29/2004 | US20040018598 Chemical intermediate for discodermolide, epothilone |
| 01/29/2004 | US20040016906 Difluoromethyl ether derivative and process for producing the same |
| 01/28/2004 | EP1384719A1 Inhibitors of the glucosyl ceramide synthase enzyme useful for the treatment of cancers, sphingolipidosis and microbial infections |
| 01/28/2004 | EP1023260B1 Process for preparing beta-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones |
| 01/28/2004 | CN1471494A Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683211 Fungicides for crops |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | CA2098821C Benzodioxane derivatives |
| 01/22/2004 | WO2004006878A1 Merocyanine derivatives for cosmetic use |
| 01/22/2004 | WO2003044065A3 Microstructure modifier for anionic polymerization |
| 01/22/2004 | US20040014991 Crystallization, aqueous extraction, controlling the geometry of the crystals formed, separation, drying and recovery of the purified lactide |
| 01/22/2004 | DE10228183A1 3,3,4,4-Tetrafluorcyclopentanverbindungen 3,3,4,4-tetrafluoroethane cyclopentadiene compounds |
| 01/21/2004 | CN1135229C Water soluble azoles as broad-spectrum antifungals |
| 01/15/2004 | WO2004005278A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 01/15/2004 | CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 01/14/2004 | EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468103A Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 01/14/2004 | CN1134428C Process for preparation of macrocyclic esters |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/13/2004 | US6677488 Substituted biphenyl compounds for the treatment of inflammation |
| 01/08/2004 | US20040006050 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/08/2004 | US20040004207 Difluoromethyl ether derivative and process for producing the same |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377566A1 Glycolide production process, and glycolic acid oligomer for glycolide production |
| 01/07/2004 | EP1377373A1 Improved method for producing unsaturated cyclic ethers |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/06/2004 | US6673937 Analogs of deoxypreussomerin, palmarumycin cpi and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system |
| 01/06/2004 | US6673934 4-amino-2-(1-aryloxy-ethyl)phenol compound |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/02/2004 | EP1375493A1 Process for the preparation of an dioxane acetic acid ester |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373199A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 01/02/2004 | EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373142A1 Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst |
| 01/02/2004 | EP1140799B1 Novel propargylether derivatives |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 12/31/2003 | WO2004000783A1 Aminoalkylphenols, methods of using and making the same |
| 12/31/2003 | WO2004000771A1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media |
| 12/31/2003 | WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/30/2003 | US6670473 Inhibitors of nitric oxide synthase (nos) |
| 12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
| 12/25/2003 | WO2003106447A1 Process for the preparation of dioxane acetic acid esters |
| 12/25/2003 | US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones |
| 12/24/2003 | WO2003106443A1 1-phenylalkyl-piperazines |
| 12/24/2003 | CN1463263A Method to inhibit ethylene responses in plants |
| 12/24/2003 | CA2489449A1 1-phenylalkyl-piperazines |
| 12/23/2003 | US6667307 HIV protease |
| 12/18/2003 | WO2003104203A1 Therapeutic molecules and methods-1 |
| 12/18/2003 | WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
| 12/18/2003 | WO2003103660A1 Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 12/18/2003 | WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors |
| 12/18/2003 | WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors |
| 12/18/2003 | US20030230737 A tetrafluoroethane-dicyclohexyl ester derivatives, electrooptical displays |
| 12/18/2003 | CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
| 12/18/2003 | CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif |
| 12/18/2003 | CA2486581A1 Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 12/17/2003 | EP1206467B1 N-heterocyclic derivatives as nos inhibitors |
| 12/17/2003 | CN1462267A Method for producing ketocarbodylic acid derivatives |